BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 29
• 30
• 31

• Business

  Sanford I. Weill Retires As Chair Of The Weill Cornell Medical College Board Of Overseers After 20 Years Of Transformative Leadership

  December 9, 2014

   · 

  10 min read
• Business

  Wexford Science & Technology, LLC Announces 283,000 Square Foot Expansion Of Wake Forest University Baptist Medical Center Innovation Quarter

  December 9, 2014

   · 

  4 min read
• Zecotek Photonics Inc. Receives Patent From Japanese Patent Office For Its MAPD Silicon Photomultiplier

  December 9, 2014

   · 

  4 min read
• BioMidwest

  KemPharm, Inc. Completes Pre-IND Meeting With FDA For NME Prodrug Of Hydromorphone, KP511

  December 9, 2014

   · 

  2 min read
• Business

  Varian Medical Systems Schedules First Quarter FY2015 News Release And Conference Call

  December 9, 2014

   · 

  2 min read
• Biotech Beach

  AVANIR Pharmaceuticals Release: Through Laughter And Tears Comes First-Ever Documentary About Life With Pseudobulbar Affect (PBA)

  December 9, 2014

   · 

  5 min read
• Drug Development

  bluebird bio Announces Data Demonstrating First Four Patients With ß-Thalassemia Major Treated With LentiGlobin® Are Transfusion-Free

  December 9, 2014

   · 

  12 min read
• Drug Development

  Seattle Children’s Research Institute’s Reprogrammed T Cell Immunotherapy Clinical Trial Boasts 85% Complete Remission Rate In Children With Relapsed Leukemia

  December 9, 2014

   · 

  3 min read
• Biotech Bay

  BioPharmX Corporation Release: Introducing Violet Iodine, New Once-Daily, Non-Prescription Pill For Relief Of Premenstrual Breast Discomfort*

  December 9, 2014

   · 

  6 min read
• Drug Development

  Vaccinex, Inc. Provides An Update On Its VX15/2503 Phase 1 Clinical Trial In Cancer Patients

  December 9, 2014

   · 

  2 min read